INS and type 2 diabetes mellitus: In addition, a considerable number of patients were being treated with sulfonylureas and/or alpha glucosidase inhibitors, and one patient in each group was being treated with pioglitazone, an insulin-sensitizing drug that has been shown to reduce VFA in patients with type 2 diabetes [41].